4.09
Exozymes Inc (EXOZ) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Research and Development |
28.29%
1.4382
|
1.121 | 1.1122 | 1.2168 | 0.803 |
| Operating Income/Loss |
23.75%
-2.9539
|
-2.387 | -2.6955 | -2.5222 | -2.548 |
| Income/Loss From Continuing Operations Before Tax |
21.45%
-2.8786
|
-2.3702 | -2.7602 | -2.287 | -2.3603 |
| Net Income/Loss |
21.45%
-2.8786
|
-2.3702 | -2.655 | -2.287 | -2.3603 |
| Basic Average Shares |
2.38%
8.6602
|
8.4588 | - | 8.3873 | 8.3773 |
| Diluted Average Shares |
2.38%
8.6602
|
8.4588 | - | 8.3873 | 8.3773 |
| Basic Earnings Per Share |
17.86%
-0.33
|
-0.28 | - | -0.27 | -0.28 |
| Diluted Earnings Per Share |
17.86%
-0.33
|
-0.28 | - | -0.27 | -0.28 |
자본화:
|
볼륨(24시간):